Speech as a Biomarker for Disease Detection

Priberam Labs

Instituto Superior Técnico, Anfiteatro VA5

Abstract:Today’s overburdened health systems face numerous challenges, exacerbated by an aging population. Speech emerges as a ubiquitous biomarker with strong potential for the development of low-cost, remote testing tools for several diseases. In fact, speech encodes information about a plethora of diseases, which go beyond the so-called speech and language disorders, and include neurodegenerative, psychiatric, and respiratory diseases.Recent advances in speech processing and machine learning have enabled the automatic detection of these diseases. Despite promising results, this research area faces challenges, primarily due to dataset limitations and the overlap of speech-affecting diseases, which often coexist and produce similar speech manifestations.These challenges guide our latest research, where we discuss the characterization of normative speech. Similar to common blood tests, we explore reference intervals for interpretable speech features (acoustic and linguistic) as a first step toward adopting speech analysis for multidisease screening. We leverage deviations from these references to detect Alzheimer’s and Parkinson’s diseases using different classifiers, namely Neural Additive Models for enhanced interpretability.Additionally, we explore bridging black-box models and interpretability by using large language models to annotate high-level, low-dimensional, interpretable characteristics of speech transcriptions, termed macro-descriptors—such as text coherence and lexical diversity. Using only four macro-descriptors, we outperformed conventional text-based Alzheimer’s disease detection methods. Bio:Catarina Botelho received her B.Sc. and M.Sc. degrees in Biomedical Engineering from Instituto Superior Técnico (IST), University of Lisbon, in 2018, and completed her Ph.D. in Electrical and Computer Engineering at IST and INESC-ID in 2024. Her MSc and PhD work has been distinguished by two awards from IST and University of Lisbon.Currently, she is a researcher at INESC-ID, contributing to the Accelerat.AI project. She has held positions as a research intern at Google AI, Toronto, and as a visitor researcher at the Cognitive Systems Lab, University of Bremen. She was involved in the student advisory committee of the International Speech Communication Association (ISCA-SAC), since 2020 to 2023, acting as Coordinator in 2022. Her scientific interests lie on speech and language technology for healthcare.<a href="https://www.priberam.com/" title="https://www.priberam.com/" target="_blank" data-msys-clicktrack="0" rel="nofollow noopener noreferrer">www.priberam.com</a>

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

Speech as a Biomarker for Disease Detection

More events from Priberam Labs

Discover more events from Priberam Labs, from Science & Tech to other experiences you might love.

Still looking for the right event?

Explore all events in Lisboa and filter by date, category, and more to find the perfect fit.

Speech as a Biomarker for Disease Detection

More events from Priberam Labs

Discover more events from Priberam Labs, from Science & Tech to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.

Still looking for the right event?

Explore all events in Lisboa and filter by date, category, and more to find the perfect fit.